The concept that pro-inflammatory adipokines are important in hypertension risk may not necessarily be surprising since previous studies have shown that other inflammatory markers, such as CRP are increased in patients with obesity, DMT2 and hypertension, as well as predict the development of these diseases [22], [23], [24]. This evidence concerns the gene CRP and obesity disorder.